Discovery and Characterisation of Undefined Ubiquitin and Ubiquitin-like E3 Ligases
In plain English
AI plain-English summaryCells tag unwanted proteins with a small molecular marker called ubiquitin to mark them for destruction, but the enzymes that attach these tags are still being discovered. This matters because ubiquitin and its relatives, ubiquitin-like proteins (Ubls), control nearly every process inside a cell—from how it divides to how it fights viruses. When these tagging systems go wrong, they contribute to cancer and other diseases. The E3 ligase enzymes that select which proteins get tagged are prime targets for new drugs, yet many E3s remain unknown, and there is no reliable way to measure their activity inside living cells. The researcher plans to find new E3 ligases, map their atomic structures, and develop chemical probes to track how they work. A key goal is to create a general, quantitative method to measure E3 activity in cells—a tool that currently does not exist. If successful, this would accelerate the development of next-generation medicines that can switch specific E3s on or off, potentially leading to more precise treatments for cancer and viral infections. This is fundamental science: the immediate payoff is a deeper understanding of cellular control systems, but past work on ubiquitin has already led to drugs for multiple myeloma, so the practical potential is real.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Discovery AwardPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know